pharmaphorum1d
The UK pharma market – Accelerating Access or still stuck in the slow lane?
Originally scheduled for publication in April, the AAR has now been delayed until after the UK's high stakes EU referendum on 23 June. Nevertheless, the pharma industry believes the AAR represents ...
pharmaphorum2d
Brexit makes UK pharma market less attractive – can a more collaborative culture redeem it?
Big questions remain about whether the UK can remain aligned with the European Medicines Agency, without which the pharma industry has warned that the UK could be relegated from its current ...
Contract Pharma6d
The Evolution of Strategic Partnerships in the Pharmaceutical Industry
The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic ...
Forbes5y
The Future of Pharma: The Role Of Biotech Companies
Despite the growth of the world’s population and the increasing demand for drugs, the pharmaceutical industry has traditionally not innovated at the same pace. According to the BBC, Dr. Kees de ...
FiercePharma2d
AstraZeneca scraps £450M expansion at UK vaccine plant, citing reduced government contribution
AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the ‘they won’t’ camp ...